Search

Search Constraints

You searched for: Author/Creator Chandra, Priya

Search Results

1. 23: ANTICOAGULATION DURING PEDIATRIC ECMO: EVALUATION OF EFFICACY AND COST. (15th December 2022)

2. [O2–17–03]: A PHASE I STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF RO7105705 IN HEALTHY VOLUNTEERS AND PATIENTS WITH MILD‐TO‐MODERATE AD. (1st July 2017)

4. Disposition and metabolism of [14C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects. (1st November 2016)

6. J08 A phase 2 open label study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of intravenous ANX005 in patients with, or at risk of, manifest Huntington's disease (HD). (12th September 2022)

7. PEDS10: Development of an Anticoagulation Stewardship Program for Pediatric ECMO-Initial Outcome Analysis. (15th June 2022)

8. Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction. Issue 4 (August 2016)